Cargando…

ZG16 promotes T-cell mediated immunity through direct binding to PD-L1 in colon cancer

Immunotherapy using programmed cell death 1 (PD1) inhibitors has shown great efficacy in colorectal cancer patients harboring mismatch-repair-deficient (dMMR) and microsatellite instability-high (MSI-H) alterations. We previously showed a negative correlation of zymogen granule protein 16 (ZG16) wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Hui, Yao, Wu, Yin, Yuhui, Li, Yizhen, Ding, Yi, Wang, Liang, Zhang, Mingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281127/ https://www.ncbi.nlm.nih.gov/pubmed/35831911 http://dx.doi.org/10.1186/s40364-022-00396-y

Ejemplares similares

ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer
por: Meng, Hui, et al.
Publicado: (2020)

Conformational switches and redox properties of the colon cancer‐associated human lectin ZG16
por: Javitt, Gabriel, et al.
Publicado: (2021)

Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer
por: Meng, Hui, et al.
Publicado: (2018)

Identification of ZG16B as a prognostic biomarker in breast cancer
por: Lu, Haotian, et al.
Publicado: (2020)

A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival
por: Wang, Wei, et al.
Publicado: (2020)

Recent Wg/Zg measurements at ATLAS
por: Gregersen, K
Publicado: (2013)

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
por: Meng, Hui, et al.
Publicado: (2023)

Wg and Zg Production Measurements with the ATLAS Detector
por: Bocci, A
Publicado: (2011)

Structural Basis for Multiple Sugar Recognition of Jacalin-related Human ZG16p Lectin
por: Kanagawa, Mayumi, et al.
Publicado: (2014)

Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer
por: Chen, Xiaobing, et al.
Publicado: (2016)

Determination of the LEP centre-of-mass energy from Zg events
por: Graugès-Pous, E
Publicado: (2000)

Comparison of Chicken Immune Responses to Immunization with Vaccine La Sota or ZG1999HDS Strain of Newcastle Disease Virus
por: Nedeljković, Gordana, et al.
Publicado: (2022)

Signal Characterization for ATLAS Run-II Resonance Search in Zg Final States
por: POLLOCK, James Wesley Yates
Publicado: (2015)

Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease
por: Costa-da-Silva, Ana Caroline, et al.
Publicado: (2021)

Essential preanalytics in PD‐L1 immunocytochemistry
por: t Hart, Nils A, et al.
Publicado: (2018)

KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery
por: Martin-Lorenzo, Marta, et al.
Publicado: (2014)

Human oral lectin ZG16B acts as a cell wall polysaccharide probe to decode host–microbe interactions with oral commensals
por: Ghosh, Soumi, et al.
Publicado: (2023)

Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: Yang, Haitang, et al.
Publicado: (2020)

X‐ray structure and mechanism of ZgHAD, a l‐2‐haloacid dehalogenase from the marine Flavobacterium Zobellia galactanivorans
por: Grigorian, Eugénie, et al.
Publicado: (2023)

RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination
por: Zhang, Yangyang, et al.
Publicado: (2023)

Complete Genome Sequence of ZG49, a T7-Like Bacteriophage Lytic to Escherichia coli Isolates
por: Shi, Hongyan, et al.
Publicado: (2018)

Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs
por: Wang, Qian, et al.
Publicado: (2022)

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
por: Xu-Monette, Zijun Y., et al.
Publicado: (2017)

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
por: Brochez, Lieve, et al.
Publicado: (2018)

A cautionary note regarding detection of PD-L1 expression by tumour-associated macrophages
por: McCoy, Melanie J., et al.
Publicado: (2017)

Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’
por: Jacquelot, Nicolas, et al.
Publicado: (2018)

PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributions
por: Mills, Anne M., et al.
Publicado: (2017)

Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: White, Michael G., et al.
Publicado: (2020)

PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma
por: Steiner, Raphael E., et al.
Publicado: (2023)

Erratum: Addition of Co-Authors: Up-regulation of IGF Binding Protein-3 Inhibits Colonic Inflammatory Response
por: Kim, Soon Chul, et al.
Publicado: (2018)

Immunogenicity of Newcastle disease virus strain ZG1999HDS applied oculonasally or by means of nebulization to day-old chicks
por: Cvetić, Željko, et al.
Publicado: (2021)

Optimization and Chemical Characterization of Biosurfactant Produced from a Novel Pseudomonas guguanensis Strain Iraqi ZG.K.M
por: Ghazi Faisal, Zeena, et al.
Publicado: (2023)

Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
por: Liu, Chaoqi, et al.
Publicado: (2017)

Diagnostic values of indirect immunofluorescence using salt-split skin, direct immunofluorescence and BP180 NC16A ELISA on bullous pemphigoid
por: Li, Suo, et al.
Publicado: (2022)

Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
por: Rodriguez, Ismael, et al.
Publicado: (2023)

Allocated but not treated: the silent 16%
por: Lee, Todd C, et al.
Publicado: (2022)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

A Rare Case of Ascending Colon Perforation Caused by a Large Fish Bone
por: Hu, Jian-Hao, et al.
Publicado: (2017)

Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
por: Shi, Yehui, et al.
Publicado: (2020)

TMEM16A Potentiation: Possible Drawbacks
por: Olschewski, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6duqs3enki2mj07pmu31unv63